Ke Zhang
Zhuhai, 519000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Verteporfin-loaded hydrogel targeting YAP-mediated MDSCs recruitment for the treatment of residual tumors after incomplete radiofrequency ablation.
Journal: Theranostics
Published: June 11, 2025
Targeting SUMOylation with an injectable nanocomposite hydrogel to optimize radiofrequency ablation therapy for hepatocellular carcinoma.
Journal: Journal of nanobiotechnology
Published: January 16, 2024
STING agonist-based hydrogel enhances immune activation in synergy with radiofrequency ablation for hepatocellular carcinoma treatment.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: August 03, 2023
Lu3+-based nanoprobe for virtual non-contrast CT imaging of hepatocellular carcinoma.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: March 03, 2022
Performance of adding hepatobiliary phase image in magnetic resonance imaging for detection of hepatocellular carcinoma: a meta-analysis.
Journal: European radiology
Published: December 08, 2021
Arsenite-loaded albumin nanoparticles for targeted synergistic chemo-photothermal therapy of HCC.
Journal: Biomaterials science
Published: November 30, 2021
Specific MiRNAs in naïve T cells associated with Hepatitis C Virus-induced Hepatocellular Carcinoma.
Specific MiRNAs in naïve T cells associated with Hepatitis C Virus-induced Hepatocellular Carcinoma.
Journal: Journal of Cancer
Published: June 17, 2020
ZnAs@SiO2 nanoparticles as a potential anti-tumor drug for targeting stemness and epithelial-mesenchymal transition in hepatocellular carcinoma via SHP-1/JAK2/STAT3 signaling.
Journal: Theranostics
Published: December 21, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026